The Ischemic Stroke drugs in development market research report provides comprehensive information on the therapeutics under development for Ischemic Stroke, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Ischemic Stroke. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Ischemic Stroke and features dormant and discontinued products.
GlobalData tracks 202 drugs in development for Ischemic Stroke by 182 companies/universities/institutes. The top development phase for Ischemic Stroke is preclinical with 76 drugs in that stage. The Ischemic Stroke pipeline has 179 drugs in development by companies and 23 by universities/ institutes. Some of the companies in the Ischemic Stroke pipeline products market are: Allife Medical Science and Technology, Suzhou Pharmavan Cancer Research Center and Saillant Therapeutics.
The key targets in the Ischemic Stroke pipeline products market include Plasminogen, Coagulation Factor XI, and Free Radical.
The key mechanisms of action in the Ischemic Stroke pipeline product include Plasminogen Activator with six drugs in Phase III. The Ischemic Stroke pipeline products include 16 routes of administration with the top ROA being Intravenous and 18 key molecule types in the Ischemic Stroke pipeline products market including Small Molecule, and Cell Therapy.
Ischemic Stroke overview
Ischemic stroke occurs when there is a disruption of blood flow to a part of the brain, leading to a lack of oxygen and nutrients. This can happen when a blood vessel that supplies blood to the brain becomes blocked or narrowed, often due to the formation of a blood clot or plaque buildup within the vessel. The blockage can occur within the blood vessels of the brain itself (cerebral arteries) or can be due to emboli, which are clots or debris that travel from other parts of the body to the brain. Ischemic strokes are the most common type of stroke, accounting for the majority of stroke cases. There are two main subtypes of ischemic stroke: 1.Thrombotic stroke occurs when a blood clot (thrombus) forms within one of the arteries that supply blood to the brain. The clot may develop in an already narrowed or atherosclerotic artery. 2. Embolic stroke happens when a blood clot or other material (an embolus) forms in another part of the body, such as the heart or a large artery, and then travels to the brain through the bloodstream, causing a blockage in a smaller blood vessel in the brain.
For a complete picture of Ischemic Stroke’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
